About
Cartography Biosciences
Building a smarter roadmap for precision therapeutics.
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens. The company provides a differentiated oncology pipeline of antibody-based therapies to target tumors more precisely than existing therapeutics. Its ATLAS and SUMMIT drug discovery platforms are powered by an industry-leading, fully integrated dataset spanning hundreds of thousands of cell states across the healthy body and large-scale profiling of individual cells from patient tumors.
HQSan Francisco, United States IndustryBiotechnology Research